These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33664595)

  • 21. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial.
    Abas MN; Tan PC; Azmi N; Omar SZ
    Obstet Gynecol; 2014 Jun; 123(6):1272-1279. PubMed ID: 24807340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of early medical management of nausea and vomiting of pregnancy.
    Lacasse A; Rey E; Ferreira E; Morin C; Bérard A
    Birth; 2009 Mar; 36(1):70-7. PubMed ID: 19278386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital admission for hyperemesis gravidarum: a nationwide study of occurrence, reoccurrence and risk factors among 8.2 million pregnancies.
    Fiaschi L; Nelson-Piercy C; Tata LJ
    Hum Reprod; 2016 Aug; 31(8):1675-84. PubMed ID: 27251205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of Assisted Reproductive Technology in the Medical Birth Registry of Norway Versus the Norwegian Prescription Database.
    Reigstad MM; Storeng R; Furu K; Bakken IJ; Engeland A; Larsen IK
    Epidemiology; 2020 Sep; 31(5):681-686. PubMed ID: 32639249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment options for hyperemesis gravidarum.
    Abramowitz A; Miller ES; Wisner KL
    Arch Womens Ment Health; 2017 Jun; 20(3):363-372. PubMed ID: 28070660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of antiemetic medication use during pregnancy: A multi-country retrospective cohort study.
    Fisher A; Paterson JM; Winquist B; Wu F; Reynier P; Suissa S; Dahl M; Ma Z; Lu X; Zhang J; Raymond CB; Filion KB; Platt RW; Moriello C; Dormuth CR;
    PLoS One; 2022; 17(12):e0277623. PubMed ID: 36454900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Egerton-Warburton D; Meek R; Mee MJ; Braitberg G
    Ann Emerg Med; 2014 Nov; 64(5):526-532.e1. PubMed ID: 24818542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of statins and other lipid-modifying agents across pregnancy: A nationwide drug utilization study in Norway in 2005-2018.
    Christensen JJ; Bogsrud MP; Holven KB; Retterstøl K; Veierød MB; Nordeng H
    Atherosclerosis; 2023 Mar; 368():25-34. PubMed ID: 36522216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.
    Dormuth CR; Winquist B; Fisher A; Wu F; Reynier P; Suissa S; Dahl M; Ma Z; Lu X; Zhang J; Raymond CB; Filion KB; Platt RW; Moriello C; Paterson JM;
    JAMA Netw Open; 2021 Apr; 4(4):e215329. PubMed ID: 33890993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of vomiting and antiemetic use in pregnancy with levels of circulating GDF15 early in the second trimester: A nested case-control study.
    Petry CJ; Ong KK; Burling KA; Barker P; Goodburn SF; Perry JRB; Acerini CL; Hughes IA; Painter RC; Afink GB; Dunger DB; O'Rahilly S
    Wellcome Open Res; 2018; 3():123. PubMed ID: 30345390
    [No Abstract]   [Full Text] [Related]  

  • 31. A pilot study of intravenous ondansetron for hyperemesis gravidarum.
    Sullivan CA; Johnson CA; Roach H; Martin RW; Stewart DK; Morrison JC
    Am J Obstet Gynecol; 1996 May; 174(5):1565-8. PubMed ID: 9065130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.
    Plosker GL; Milne RJ
    Pharmacoeconomics; 1992 Oct; 2(4):285-304. PubMed ID: 10147044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetic predictors of nausea and vomiting of pregnancy severity and response to antiemetic therapy: a pilot study.
    Lehmann AS; Renbarger JL; McCormick CL; Topletz AR; Rouse C; Haas DM
    BMC Pregnancy Childbirth; 2013 Jun; 13():132. PubMed ID: 23786674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost and cost-effectiveness analysis of ondansetron versus metoclopramide regimens: a hospital perspective from Italy.
    Ballatori E; Roila F; Berto P; De Angelis V; Neri C; Olivieri A; Tonato M; Del Favero A
    Pharmacoeconomics; 1994 Mar; 5(3):227-37. PubMed ID: 10146897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum.
    Koren G; Maltepe C
    J Obstet Gynaecol; 2004 Aug; 24(5):530-3. PubMed ID: 15369934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.
    Engeland A; Bramness JG; Daltveit AK; Rønning M; Skurtveit S; Furu K
    Br J Clin Pharmacol; 2008 May; 65(5):653-60. PubMed ID: 18294334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promethazine compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial.
    Tan PC; Khine PP; Vallikkannu N; Omar SZ
    Obstet Gynecol; 2010 May; 115(5):975-981. PubMed ID: 20410771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects.
    Parker SE; Van Bennekom C; Anderka M; Mitchell AA;
    Obstet Gynecol; 2018 Aug; 132(2):385-394. PubMed ID: 29995744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.